SCHEMBL5656748

SCHEMBL5656748

COc1cc(C(=O)O)c2cc(CO)oc2c1OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.43
KDM4E B2RXH2 4/20 0.42
POLB P06746 3/20 0.42
GAA P10253 1/20 0.42
CA12 O43570 3/20 0.42
CA1 P00915 3/20 0.42
CA7 P43166 3/20 0.42
CA9 Q16790 3/20 0.42
CA13 Q8N1Q1 2/20 0.42
CA2 P00918 2/20 0.42
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
RELA Q04206 1/20 0.39
TDP1 Q9NUW8 2/20 0.39
TPMT P51580 1/20 0.39
MAPT P10636 1/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658621 0.87 KDM4E (0.49) PKMKDM4EPOLBGAACA12
SCHEMBL21230540 0.77 KDM4E (0.44) KDM4EPOLBGAACA12CA1
SCHEMBL5655596 0.75 KDM4E (0.48) PKMKDM4EPOLBGAACA12
SCHEMBL5669321 0.73 KDM4E (0.49) PKMKDM4EPOLBCA12CA1
SCHEMBL5659653 0.73 PDE4A (0.50) PKMKDM4EPOLBGAACA12
SCHEMBL5657720 0.73 KDM4E (0.46) KDM4EPOLBGAAALDH1A1SMN1; SMN2
SCHEMBL5657121 0.72 MEN1 (0.43) KDM4EPOLBMEN1ALDH1A1KMT2A
SCHEMBL21230539 0.72 KDM4E (0.39) KDM4EPOLBGAACA12CA1
SCHEMBL26244747 0.72 MCL1 (0.40) KDM4EPOLBGAARELAMAPT
SCHEMBL7053201 0.71 PDE4A (0.60) KDM4ECA12CA1CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030130-B2 Benzofuran derivatives and their use as antibacterial agents ARPIDA AG (CH) 2006-04-18 US disclosed
EP-1307445-B1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2005-12-21 EP disclosed
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents EVOLVA SA (CH) 2004-02-19 US disclosed
EP-1307445-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS Arpida AG, (CH) 2003-05-07 EP disclosed
WO-2002010157-A1 BENZOFURAN DERIVATIVES AND THEIR USE AS ANTIBACTERIAL AGENTS ARPIDA AG (CH) 2002-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040034047-A1 Benzofuran derivatives and their use as antibacterial agents SBDS, BPTF, DCXR PKM 2044/4885KDM4E 1540/4885POLB 731/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.